Glimepiride 2 MG tablet 100S
Ended Awarded Last action
- Contract number
- SPE2DR26F6DHB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,834
Award facts
- Contract value 100% obligated
- $2,834.01 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,834.01 to AmerisourceBergen Drug Corp on January 15, 2026, for the supply of Glimepiride 2 mg tablets (100 count). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of January 16, 2026 and performance to be executed at the contractor's Conshohocken, Pennsylvania facility. The award represents a task order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.999 billion through December 2031, which serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor providing critical medical procurement support to federal agencies, particularly the Department of Defense and veteran healthcare systems. The company maintains broad capability across multiple therapeutic domains and has demonstrated consistent competitiveness in open federal procurement. This delivery order for Glimepiride, a diabetes management medication, exemplifies the routine pharmaceutical supply operations executed under the comprehensive DLA Troop Support Medical IDC, which encompasses a wide range of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities required across the military's global healthcare infrastructure.
Quick answers
Who was awarded contract SPE2DR26F6DHB?
SPE2DR26F6DHB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 15, 2026.
How much is contract SPE2DR26F6DHB worth?
The government has obligated $2,834 on SPE2DR26F6DHB.
Is contract SPE2DR26F6DHB an order under another contract?
Yes. SPE2DR26F6DHB is a delivery order under SPE2DR25D2213, an indefinite delivery contract.
Was contract SPE2DR26F6DHB competed?
The extent of competition for SPE2DR26F6DHB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award